Latest news about Alafair Biosciences
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Alafair Biosciences reported 51% year-over-year revenue growth in 2024, driven by its VersaWrap Hydrogel Sheet, an FDA-cleared, plant-based medical device. The company surpassed 24,000 implants nationwide, expanded its distribution network by 64%, and was recognized as the 11th fastest-growing private company in Health Products by Inc. 5000[4].
Alafair Biosciences announced it has surpassed 22,000 patient implants of its VersaWrap Hydrogel Sheet, a significant milestone highlighting the product's growing market adoption and positive impact on patient outcomes, with the company generating positive net income and EBITDA in 2024[5].
Alafair Biosciences' Sarah Mayes, Ph.D., was named to Inc.'s 2025 Female Founders 500 List, recognizing her leadership and innovation in the company[3].
Open job positions at Alafair Biosciences
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

